Childhood Cancer

You are here

All grants tagged with "Acute Myeloid Leukemia (AML)"

Targeting Oncogenic RAS in Pediatric Leukemia

Loren Walensky, MD/PhD

Dana-Farber Cancer Institute

Innovation Grants, Awarded 2018

Immuno-therapeutic Targeting of CD56 in CBA2T3/GLIS2-AML in Children

Soheil Meshinchi, MD/PhD

Fred Hutchinson Cancer Research Center

Reach Grants, Awarded 2018

Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia

Nick van Gastel, PhD

Harvard University

Young Investigator Grants, Awarded 2018

Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML

Maxim Pimkin, MD/PhD

Dana-Farber Cancer Institute

Young Investigator Grants, Awarded 2018

Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy

Colin Godwin, MD

Fred Hutchinson Cancer Research Center

Young Investigator Grants, Awarded 2018

Clinical Epidemiology Research to Improve Treatment Outcomes and Supportive Care in Pediatric AML

Doreen Z. Chang

Drexel University College of Medicine

POST Program Grants, Awarded 2018

Translational Utility of New Models of Human AML

Kelly Roberts

Xavier University

POST Program Grants, Awarded 2018

Targeted Inhibition of CREB for the Treatment of Pediatric Acute Myeloid Leukemia

Yvonne Lee

Oakland University

POST Program Grants, Awarded 2018

Investigating the Interplay between Nucleophosmin and Caspase-2 in Determining Chemosensitivity in Childhood AML

Kenneth McSherry

University College Dublin

POST Program Grants, Awarded 2018

Quantitative Evaluation of CAR-T Cell Inhibition Mediated by PD1

Kevin Huang

University of Michigan

POST Program Grants, Awarded 2018

Pages

All childhood cancer types